Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine and Naltrexone for Chronic Itch in Atopic Dermatitis
NCT02268448Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2015
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in atopic dermatitis (AD) comparing Clonidine with Naltrexone (2 arms). Primary endpoint: Reduction in Itch at 3 months. Started Jul 2015; status: completed.
02
Drugs
clonidinenaltrexone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02268448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268448.